Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 14 04:00PM ET
25.65
Dollar change
+0.02
Percentage change
0.07
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y- Shs Outstand Perf Week-0.49%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- Total Holdings32 Perf Month4.86%
Fund Family Bond Type Tagsinnovation Return% 5Y- AUM54.24M Perf Quarter-3.63%
Index- Average Maturity Tagshealthcare Return% 10Y NAV% Perf Half Y-
Index Weighting Commodity Type Tagsbiotechnology Return% SI NAV/sh Perf Year-
Active/Passive Quant Type Tagsmedical Flows% 1M2.00% 52W Range23.35 - 27.76 Perf YTD9.64%
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M1.89% 52W High-7.61% Beta-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD2.00% 52W Low9.82% ATR (14)0.45
Expense0.79% Structure Type Region Flows% 1Y RSI (14)52.24 Volatility1.46% 1.51%
Option/ShortNo / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.30 Prev Close25.63
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume2.25K Price25.65
SMA20-0.62% SMA502.53% SMA2001.44% Trades Volume671 Change0.07%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.